Premia Global Advisors’s Bio-Techne TECH Stock Holding History

Premia Global Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-136	Closed	-$4K	–	418
2017 Q4	$4K	Buy	+136	New	+$4.32K	﹤0.01%	358

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Premia Global Advisors's TECH Position: Q1 2018 in Review

Premia Global Advisors sold out of Bio-Techne (TECH) in Q1 2018, closing a stake of 136 shares — an estimated $4K sold.

Premia Global Advisors first reported a position in TECH in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 332 funds tracked by Wall St. Rank hold TECH as of Q1 2018.

Premia Global Advisors reported no remaining Bio-Techne position as of Q1 2018 after selling out during the quarter.
Premia Global Advisors sold 136 Bio-Techne shares in Q1 2018, an estimated $4K.
Premia Global Advisors first reported a position in Bio-Techne in Q4 2017 and held it in 1 quarter.
Premia Global Advisors's Bio-Techne position peaked at $4K in Q4 2017.
332 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2018.

Based on Premia Global Advisors's 13F filing for Q1 2018, filed 14 May 2018.